XML 20 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Stockholders' Equity - USD ($)
Total
At-the-Market Financing Facility [Member]
Securities Purchase Agreement [Member]
Underwritten Registered Offering [Member]
Common Stock [Member]
Common Stock [Member]
At-the-Market Financing Facility [Member]
Common Stock [Member]
Securities Purchase Agreement [Member]
Common Stock [Member]
Underwritten Registered Offering [Member]
Additional Paid-in capital [Member]
Additional Paid-in capital [Member]
At-the-Market Financing Facility [Member]
Additional Paid-in capital [Member]
Securities Purchase Agreement [Member]
Additional Paid-in capital [Member]
Underwritten Registered Offering [Member]
Accumulated Deficit [Member]
Balance, at beginning at Mar. 31, 2019 $ 9,667,882       $ 10,397       $ 95,472,181       $ (85,814,696)
Balance, at beginning (in shares) at Mar. 31, 2019         103,946,048                
Issuance of common stock   $ 1,529,246 $ 19,857,719 $ 3,885,172   $ 136 $ 1,000 $ 800   $ 1,529,110 $ 19,856,719 $ 3,884,372  
Issuance of common stock (in shares)           1,361,315 10,000,000 8,000,000          
Cashless exercise of warrants (in shares)         4,889                
Proceeds from the exercise of stock options (in shares) 0                        
Stock based compensation $ 6,085,673               6,085,673        
Net loss (22,000,556)                       (22,000,556)
Balance, at end at Mar. 31, 2020 $ 19,025,136       $ 12,333       126,828,055       (107,815,252)
Balance, at end (in shares) at Mar. 31, 2020 123,312,252       123,312,252                
Issuance of common stock   $ 5,775,418 $ 93,771,865     $ 445 $ 4,000     $ 5,774,973 $ 93,767,865    
Issuance of common stock (in shares)           4,453,939 40,000,000            
Proceeds from the exercise of stock options $ 5,351,323       $ 203       5,351,120        
Proceeds from the exercise of stock options (in shares) 2,028,203       2,028,203                
Warrant to share exchange $ 3,393,775       $ 241       3,393,534        
Warrant to share exchange (in shares)         2,406,250                
Stock based compensation 3,456,895               3,456,895        
Net loss (28,978,763)                       (28,978,763)
Balance, at end at Mar. 31, 2021 $ 101,795,649       $ 17,222       $ 238,572,442       $ (136,794,015)
Balance, at end (in shares) at Mar. 31, 2021 172,200,644       172,200,644